| Accession Number | 0001193125-26-371388 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 27, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Aug 25, 2026 | Exercise/Conversion | 30,955 | $11.35 | $351,339.25 | 40,710 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Aug 25, 2026 | Sale | 25,085 | $125.47 | $3,147,354.75 | 15,625 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Aug 25, 2026 | Sale | 5,870 | $126.06 | $739,965.16 | 9,755 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Stock option (right to buy) | Derivative | Aug 25, 2026 | Exercise/Conversion | 30,955 | $0.00 | $0.00 | 169,045 | Direct | โ | View Details |